Home » Wisconsin Settles Medicaid Case With Boehringer Ingelheim
Wisconsin Settles Medicaid Case With Boehringer Ingelheim
Four Boehringer Ingelheim subsidiaries have
reached a $7.75 million settlement agreement with the state of Wisconsin to resolve civil claims involving reporting “false, fraudulent and inflated” prices for their products to Medicaid. Boehringer subsidiaries agreed to pay $7 million in restitution
to the state’s Medicaid program and $750,000 in court costs and fees. The drugmaker denies any wrongdoing.
Washington Drug Letter
Washington Drug Letter
Upcoming Events
-
28Mar
-
04Apr
-
11Apr
-
14Apr
-
25Apr
-
14May